David Michael Clark Amicus Therapeutics, Inc. (FOLD) insider trading activity

David Michael Clark is Chief People Officer of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 221,811 shares of FOLD, which is worth approximately $2.1 Million. The most recent transaction as insider was on Jan 04, 2023, when has been sold 2,692 shares (Common Stock) at a price of $12.03 per share, resulting in proceeds of $32,384. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 222K

36.31% 3M change

29.92% 12M change

Total Value Held $2.1 Million

David Michael Clark Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 04 2023	SELL Payment of exercise price or tax liability	$32,384 $12.03 p/Share	2,692 Reduced 1.1%	241,073 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$69,313 $11.93 p/Share	5,810 Reduced 2.33%	243,765 Common Stock
Jan 03 2023	SELL Open market or private sale	$102,170 $12.03 p/Share	8,493 Reduced 4.27%	190,203 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	59,372 Added 19.22%	249,575 Common Stock
Jan 02 2023	SELL Payment of exercise price or tax liability	$138,412 $12.21 p/Share	11,336 Reduced 5.4%	198,696 Common Stock
Oct 09 2022	SELL Payment of exercise price or tax liability	$57,304 $10.4 p/Share	5,510 Reduced 2.56%	210,032 Common Stock
Aug 05 2022	SELL Open market or private sale	$141,525 $12.5 p/Share	11,322 Reduced 4.99%	215,542 Common Stock

Jan 14 2022	SELL Payment of exercise price or tax liability	$133,563 $10.53 p/Share	12,684 Reduced 5.29%	226,864 Common Stock
Jan 14 2022	BUY Grant, award, or other acquisition	-	91,306 Added 27.6%	239,548 Common Stock
Jan 04 2022	SELL Payment of exercise price or tax liability	$33,596 $12.48 p/Share	2,692 Reduced 1.78%	148,242 Common Stock
Jan 02 2022	SELL Payment of exercise price or tax liability	$123,181 $11.55 p/Share	10,665 Reduced 6.6%	150,934 Common Stock
Dec 31 2021	SELL Payment of exercise price or tax liability	$84,084 $11.55 p/Share	7,280 Reduced 4.31%	161,599 Common Stock
Oct 09 2021	SELL Payment of exercise price or tax liability	$63,420 $11.51 p/Share	5,510 Reduced 3.16%	168,879 Common Stock
Apr 06 2021	BUY Grant, award, or other acquisition	-	16,883 Added 8.83%	174,389 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	27,369 Added 14.8%	157,506 Common Stock
Jan 02 2021	SELL Payment of exercise price or tax liability	$253,390 $23.09 p/Share	10,974 Reduced 7.78%	130,137 Common Stock
Oct 09 2020	SELL Payment of exercise price or tax liability	$83,311 $15.12 p/Share	5,510 Reduced 3.76%	141,111 Common Stock

DMC

David Michael Clark

Chief People Officer

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account